The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency
Abstract
PURPOSE: To evaluate testicular function in men after treatment with cytotoxic chemotherapy. PATIENTS AND METHODS: We measured testosterone, sex hormone–binding globulin (SHBG), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels in 209 men after treatment with mechlorethamine, vinblastine, procarbazine, and prednisone, hybrid chemotherapy, or high-dose chemotherapy and in 54 healthy age-matched controls. RESULTS: The mean age of the patients was 38 years (range, 19 to 68 years), and all patients had received chemotherapy between 1 and 22 years previously. Patients had significantly higher mean LH (7.9 v 4.1 IU/L; P < .0001) and FSH levels (18.8 v 3.1 IU/L; P < .0001) than controls. There was no significant difference in mean total testosterone level between the patients and controls, but there was a trend toward a lower mean testosterone/SHBG ratio in the patients (0.63 v 0.7; P = .08). Analysis of the hormonal parameters using a model that allowed for the effects of increasing age on testicular function showed evidence of significant recovery of gonadal function in the first 10 years after treatment. Fifty-two percent of patients had LH levels at or above the upper limit of normal, and 32% of patients had increased LH with testosterone levels in the lower half of the normal range, suggesting a degree of Leydig cell impairment. CONCLUSION: In a significant proportion of men, there is good evidence of Leydig cell dysfunction after cytotoxic chemotherapy. The clinical significance of this Leydig cell dysfunction is not clear, but some of these men may benefit from testosterone replacement. Further studies are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endocrine, Paracrine and Autocrine Regulation of Testicular Steroidogenesis
Huhtaniemi, I., & Toppari, J. (1995) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-0952-7_3 · Cited by 82
Cited by
Spermatogenesis After Cancer Treatment: Damage and Recovery
Howell, S. J. (2005) · Journal of the National Cancer Institute Monographs · doi:10.1093/jncimonographs/lgi003 · Cited by 506
Self-citationOsteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 363
Kenney, L. B., Laufer, M. R., Grant, F. D., Grier, H., & Diller, L. (2001) · Cancer · doi:10.1002/1097-0142(20010201)91:3<613::aid-cncr1042>3.0.co;2-r · Cited by 327
Options for fertility preservation in prepubertal boys
Wyns, C., Curaba, M., Vanabelle, B., Van Langendonckt, A., & Donnez, J. (2010) · Human Reproduction Update · doi:10.1093/humupd/dmp054 · Cited by 263
Male hypogonadism: Symptoms and treatment
Kumar, P., Kumar, N., Thakur, D., & Patidar, A. (2010) · Journal of Advanced Pharmaceutical Technology & Research · doi:10.4103/0110-5558.72420 · Cited by 142
Metadata
- Authors
- Howell, S. J., Radford, J. A., Ryder, W. D. J., & Shalet, S. M.
- Venue
- Journal of Clinical Oncology
- Published
- 1999-05
- Volume
- 17
- Issue
- 5
- Pages
- 1493-1493
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2247404961
- Cited by
- 162
- References
- 1
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency. https://app.cochat.ai/papers/10.1200/jco.1999.17.5.1493
- The paper
- Howell, S. J., Radford, J. A., Ryder, W. D. J., & Shalet, S. M. (1999). Testicular Function After Cytotoxic Chemotherapy: Evidence of Leydig Cell Insufficiency. Journal of Clinical Oncology. https://doi.org/10.1200/jco.1999.17.5.1493
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.